{"altmetric_id":1836181,"counts":{"readers":{"mendeley":4,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["GoToPER"],"posts_count":1}},"citation":{"abstract":"Bone metastases are a rare manifestation in the management of ovarian cancer and thought to be associated with a poor prognosis as sign of distant spread. Only few data exist on this rare condition. The present study aimed to more information on this very distinct patient collective.","abstract_source":"pubmed","altmetric_jid":"4f6fa4e83cf058f610002280","authors":["J Sehouli","J Olschewski","V Schotters","C Fotopoulou","K Pietzner"],"doi":"10.1093\/annonc\/mdt398","first_seen_on":"2013-10-17T10:28:19+00:00","issns":["1569-8041"],"journal":"Annals of Oncology","last_mentioned_on":1382005669,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24130264?dopt=Abstract"],"pmid":"24130264","pubdate":"2013-10-14T00:00:00+00:00","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["neoplasms"],"title":"Prognostic role of early versus late onset of bone metastasis in patients with carcinoma of the ovary, peritoneum and fallopian tube.","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/prognostic-role-early-versus-late-onset-bone-metastasis-patients-carcinoma-ovary-peritoneum-fallopia"},"altmetric_score":{"score":0.25,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.25},"context_for_score":{"all":{"total_number_of_other_articles":4508612,"mean":5.1916753366762,"rank":3600561,"this_scored_higher_than_pct":3,"this_scored_higher_than":147491,"rank_type":"exact","sample_size":4508612,"percentile":3},"similar_age_3m":{"total_number_of_other_articles":101098,"mean":7.813157521984,"rank":81731,"this_scored_higher_than_pct":1,"this_scored_higher_than":895,"rank_type":"exact","sample_size":101098,"percentile":1},"this_journal":{"total_number_of_other_articles":2299,"mean":5.0674151436031,"rank":1934,"this_scored_higher_than_pct":1,"this_scored_higher_than":38,"rank_type":"exact","sample_size":2299,"percentile":1},"similar_age_this_journal_3m":{"total_number_of_other_articles":89,"mean":7.1199545454545,"rank":70,"this_scored_higher_than_pct":1,"this_scored_higher_than":1,"rank_type":"exact","sample_size":89,"percentile":1}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Researcher":3,"Student  > Ph. D. Student":1},"by_discipline":{"Medicine and Dentistry":3,"Agricultural and Biological Sciences":1}}},"geo":{"twitter":{"US":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/GoToPER\/status\/390786218281025536","license":"public","citation_ids":[1836181],"posted_on":"2013-10-17T10:27:49+00:00","author":{"name":"PER","url":"http:\/\/gotoper.com","image":"https:\/\/pbs.twimg.com\/profile_images\/3438723869\/2416df847bccb4c5ad8da6015ba30370_normal.jpeg","description":"Physicians' Education Resource (PER) specializes in oncology and hematology CME-certified activities. We advance cancer care through professional education.","id_on_source":"GoToPER","tweeter_id":"37703552","geo":{"lt":40.31622,"ln":-74.51376,"country":"US"},"followers":4420},"tweet_id":"390786218281025536"}]}}